Novel Therapies of Hepatitis B and D

Novel Therapies of Hepatitis B and D

Hepatitis B virus (HBV) infection is a global public health issue and is a major cause of cirrhosis and hepatocellular carcinoma (HCC). Hepatitis D virus (HDV) requires the hepatitis B surface antigen (HBsAg) to replicate. The eradication of HBV, therefore, can also cure HDV. The current therapies f...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Iman Waheed Khan, Mati Ullah Dad Ullah, Mina Choudhry, Mukarram Jamat Ali, Muhammad Ashar Ali, Sam L. K. Lam, Pir Ahmad Shah, Satinder Pal Kaur, Daryl T. Y. Lau
Formaat:	Artikel
Taal:	English
Gepubliceerd in:	MDPI AG 2021-12-01
Reeks:	Microorganisms
Onderwerpen:	Hepatitis B virus (HBV) Hepatitis D virus (HDV) novel therapies siRNAs cccDNA inhibitors capsid assembly modulators
Online toegang:	https://www.mdpi.com/2076-2607/9/12/2607

Gelijkaardige items

Characterization of Hepatitis B Virus Transcripts in Chronically HBV-Infected Chimpanzees and Patients Treated with ARC-520 siRNA Demonstrates Transcriptional Silencing of cccDNA
door: Christine I. Wooddell, et al.
Gepubliceerd in: (2024-12-01)

Recent Advances in Hepatitis B Treatment
door: Georgia-Myrto Prifti, et al.
Gepubliceerd in: (2021-05-01)

Current Status and Challenges in Anti-Hepatitis B Virus Agents Based on Inactivation/Inhibition or Elimination of Hepatitis B Virus Covalently Closed Circular DNA
door: An-Qi Zhuang, et al.
Gepubliceerd in: (2023-11-01)

Recent Advances in the Development of Sulfamoyl-Based Hepatitis B Virus Nucleocapsid Assembly Modulators
door: Sandesha Nayak, et al.
Gepubliceerd in: (2023-11-01)

Hepatitis B Virus Capsid: The Core in Productive Entry and Covalently Closed Circular DNA Formation
door: Megan A. Mendenhall, et al.
Gepubliceerd in: (2023-02-01)

Gene Editing Technologies to Target HBV cccDNA
door: Maria Guadalupe Martinez, et al.
Gepubliceerd in: (2022-11-01)

Mechanisms of Hepatitis B Virus cccDNA and Minichromosome Formation and HBV Gene Transcription
door: Andoni Gómez-Moreno, et al.
Gepubliceerd in: (2024-04-01)

Inflammatory Gene Expression Associates with Hepatitis B Virus cccDNA- but Not Integrant-Derived Transcripts in HBeAg Negative Disease
door: Andrea Magri, et al.
Gepubliceerd in: (2022-05-01)

The feasibility of establishing a hamster model for HBV infection: in vitro evidence
door: Hu Zhang, et al.
Gepubliceerd in: (2024-11-01)

Chronic Hepatitis B Genotype C Mouse Model with Persistent Covalently Closed Circular DNA
door: Deok-Hwa Seo, et al.
Gepubliceerd in: (2024-12-01)

Targeting HBV cccDNA Levels: Key to Achieving Complete Cure of Chronic Hepatitis B
door: Wei He, et al.
Gepubliceerd in: (2024-12-01)

Augmented epigenetic repression of hepatitis B virus covalently closed circular DNA by interferon-α and small-interfering RNA synergy
door: Kongying Hu, et al.
Gepubliceerd in: (2024-12-01)

Advances with RNAi-Based Therapy for Hepatitis B Virus Infection
door: Fiona van den Berg, et al.
Gepubliceerd in: (2020-08-01)

Predominance of Genotype 5 Hepatitis Delta Virus Infection in a Portuguese Hepatology Unit
door: Mariana Ferreira Cardoso, et al.
Gepubliceerd in: (2024-08-01)

Crosstalk between Hepatitis B Virus and the 3D Genome Structure
door: João Diogo Dias, et al.
Gepubliceerd in: (2022-02-01)

Roles Played by DOCK11, a Guanine Nucleotide Exchange Factor, in HBV Entry and Persistence in Hepatocytes
door: Ying-Yi Li, et al.
Gepubliceerd in: (2024-05-01)

Chronic Hepatitis B Treatment Strategies Using Polymerase Inhibitor-Based Combination Therapy
door: Eriko Ohsaki, et al.
Gepubliceerd in: (2021-08-01)

HDV Pathogenesis: Unravelling Ariadne’s Thread
door: Eirini D. Tseligka, et al.
Gepubliceerd in: (2021-04-01)

Evaluation of Interfering RNA Efficacy in Treating Hepatitis B: Is It Promising?
door: Giovana Paula Angelice, et al.
Gepubliceerd in: (2024-10-01)

Cell Culture Systems for Studying Hepatitis B and Hepatitis D Virus Infections
door: Grace Sanghee Lee, et al.
Gepubliceerd in: (2023-07-01)

Lipid nanoparticle-encapsulated DOCK11-siRNA efficiently reduces hepatitis B virus cccDNA level in infected mice
door: Hikari Okada, et al.
Gepubliceerd in: (2024-09-01)

SMC5/6-Mediated Transcriptional Regulation of Hepatitis B Virus and Its Therapeutic Potential
door: Johannes Bächer, et al.
Gepubliceerd in: (2024-10-01)

Illuminating the Live-Cell Dynamics of Hepatitis B Virus Covalently Closed Circular DNA Using the CRISPR-Tag System
door: Jiahui Ding, et al.
Gepubliceerd in: (2023-04-01)

Association between intrahepatic cccDNA and the severity of liver inflammation in chronic hepatitis B virus infection patients
door: Suxian Zhao, et al.
Gepubliceerd in: (2025-01-01)

Exosomes as Conduits: Facilitating Hepatitis B Virus-Independent Hepatitis D Virus Transmission and Propagation in Hepatocytes
door: Marwa Khabir, et al.
Gepubliceerd in: (2024-05-01)

Epigenetic regulation and its therapeutic potential in hepatitis B virus covalently closed circular DNA
door: Jihua Ren, et al.
Gepubliceerd in: (2025-01-01)

Improved Specificity and Safety of Anti-Hepatitis B Virus TALENs Using Obligate Heterodimeric <i>Fok</i>I Nuclease Domains
door: Tiffany Smith, et al.
Gepubliceerd in: (2021-07-01)

Immunoinformatics and Evaluation of Peptide Vaccines Derived from Global Hepatitis B Viral HBx and HBc Proteins Critical for Covalently Closed Circular DNA Integrity
door: Umar Saeed, et al.
Gepubliceerd in: (2023-11-01)

Seroprevalence of HDV Infection among HBsAg Positive Blood Donor in Baqubah City, Iraq
door: Linda Munjed Hadi, et al.
Gepubliceerd in: (2018-09-01)

Seroprevalence of HDV Infection among HBsAg Positive Blood Donor in Baqubah City, Iraq
door: Linda Munjed Hadi, et al.
Gepubliceerd in: (2018-09-01)

Clinical and epidemiological characteristics of D hepatitis В and delta in the Republic of Dagestan
door: S. A. Magomedova, et al.
Gepubliceerd in: (2023-10-01)

Dynamics of Hepatitis B Virus Covalently Closed Circular DNA: A Mini-Review
door: Jie-Li Hu, et al.
Gepubliceerd in: (2023-02-01)

Prevalence of hepatitis D virus infection in Central Italy has remained stable across the last 2 decades with dominance of subgenotypes 1 and characterized by elevated viral replication
door: Romina Salpini, et al.
Gepubliceerd in: (2024-01-01)

A Mathematical Model for Early HBV and -HDV Kinetics during Anti-HDV Treatment
door: Rami Zakh, et al.
Gepubliceerd in: (2021-12-01)

Applications of CRISPR/Cas as a Toolbox for Hepatitis B Virus Detection and Therapeutics
door: Anuj Kumar, et al.
Gepubliceerd in: (2024-10-01)

The Circulating miRNA Profile of Chronic Hepatitis D and B Patients Is Comparable but Differs from That of Individuals with HBeAg-Negative HBV Infection
door: Daniela Cavallone, et al.
Gepubliceerd in: (2023-11-01)

HOXA‐AS2 Epigenetically Inhibits HBV Transcription by Recruiting the MTA1‐HDAC1/2 Deacetylase Complex to cccDNA Minichromosome
door: YiPing Qin, et al.
Gepubliceerd in: (2024-06-01)

Intrinsic Immune Response of HBV/HDV-Infected Cells and Corresponding Innate (Like) Immune Cell Activation
door: Christopher Groth, et al.
Gepubliceerd in: (2024-11-01)

A preregistered meta-meta-analysis on the global distribution of Hepatotropic Viruses
door: Shuaibu Suleiman Adeiza, et al.
Gepubliceerd in: (2024-11-01)

Treatment with bulevirtide in HIV-infected patients with chronic hepatitis D: ANRS HD EP01 BuleDelta and compassionate cohort
door: Victor de Lédinghen, et al.
Gepubliceerd in: (2024-08-01)